FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

763033005: Letermovir (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3637610014 Letermovir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3637611013 Letermovir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5499781000241113 létermovir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Letermovir Is a Heterocyclic compound false Inferred relationship Some
Letermovir This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cytomegalovirus terminase complex inhibitor true Inferred relationship Some
Letermovir Is a Cytomegalovirus terminase complex inhibitor true Inferred relationship Some
Letermovir Is a Quinazoline (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing letermovir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Letermovir Inferred relationship Some 1
Letermovir-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Letermovir Inferred relationship Some 1
Letermovir only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Letermovir Inferred relationship Some 1
Product containing only letermovir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Letermovir Inferred relationship Some 1
Letermovir 480 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Letermovir Inferred relationship Some 1
Letermovir 480 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Letermovir Inferred relationship Some 1
Letermovir 240 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Letermovir Inferred relationship Some 1
Letermovir 240 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Letermovir Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start